Dr. Kyle Lemond, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,458 | 275 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,039 | 79 | $0 (2024) |
| GlaxoSmithKline, LLC. | $488.47 | 26 | $0 (2024) |
| Novo Nordisk Inc | $425.39 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $343.78 | 11 | $0 (2024) |
| Amgen Inc. | $323.81 | 22 | $0 (2024) |
| PFIZER INC. | $263.55 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $258.26 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $182.15 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $156.94 | 10 | $0 (2024) |
| Axsome Therapeutics, Inc. | $116.74 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,710 | 95 | ABBVIE INC. ($410.72) |
| 2023 | $1,408 | 91 | ABBVIE INC. ($455.67) |
| 2022 | $394.78 | 25 | GlaxoSmithKline, LLC. ($105.12) |
| 2021 | $756.86 | 52 | GlaxoSmithKline, LLC. ($131.09) |
| 2020 | $176.31 | 11 | AstraZeneca Pharmaceuticals LP ($39.59) |
| 2018 | $12.50 | 1 | Merck Sharp & Dohme Corporation ($12.50) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: PAIN | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PAIN | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 308 | 450 | $91,449 | $32,310 |
| 2022 | 12 | 459 | 563 | $77,131 | $32,005 |
| 2021 | 16 | 1,415 | 1,533 | $130,317 | $70,197 |
| 2020 | 5 | 108 | 128 | $19,413 | $7,449 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 224 | $55,552 | $18,283 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $10,032 | $5,285 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,332 | $2,369 | 22.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 25 | 25 | $3,375 | $1,884 | 55.8% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 11 | 11 | $4,345 | $1,538 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $4,080 | $1,384 | 33.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,040 | $744.38 | 71.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 12 | 12 | $588.00 | $458.04 | 77.9% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 16 | 19 | $893.00 | $180.88 | 20.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $798.00 | $133.28 | 16.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 23 | $414.00 | $50.60 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 175 | $43,400 | $13,703 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $7,296 | $3,981 | 54.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 78 | 78 | $3,510 | $2,846 | 81.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 66 | 66 | $3,206 | $2,387 | 74.4% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 51 | 52 | $2,340 | $1,898 | 81.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $3,240 | $1,686 | 52.0% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 36 | 36 | $1,748 | $1,302 | 74.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,273 | $1,188 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 21 | $3,570 | $1,158 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 29 | $1,159 | $791.39 | 68.3% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 17 | 17 | $765.00 | $626.93 | 82.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $624.00 | $439.40 | 70.4% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 495 | 495 | $22,275 | $18,419 | 82.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 191 | $44,778 | $15,579 | 34.8% |
About Dr. Kyle Lemond, MD
Dr. Kyle Lemond, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1609303015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Lemond, MD has received a total of $4,458 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 275 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,458).
As a Medicare-enrolled provider, Lemond has provided services to 2,290 Medicare beneficiaries, totaling 2,674 services with total Medicare billing of $141,961. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine, Family Medicine
- Location Evansville, IN
- Active Since 05/16/2017
- Last Updated 07/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609303015
Products in Payments
- VRAYLAR (Drug) $588.07
- UBRELVY (Drug) $315.25
- AIRSUPRA (Drug) $215.74
- Otezla (Drug) $204.43
- NURTEC ODT (Drug) $197.15
- Ozempic (Drug) $192.90
- TRELEGY ELLIPTA (Drug) $190.04
- REXULTI (Drug) $182.15
- SHINGRIX (Biological) $162.64
- QULIPTA (Drug) $135.78
- CAPLYTA (Drug) $134.37
- FARXIGA (Drug) $128.04
- Auvelity (Drug) $116.74
- LEQVIO (Drug) $111.33
- Rybelsus (Drug) $109.66
- ENTRESTO (Drug) $104.38
- Aimovig (Biological) $91.13
- AREXVY (Drug) $71.18
- XARELTO (Drug) $64.19
- FLOWTRIEVER CATHETER, S (Device) $61.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Evansville
Joseph Adongay, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $14,409
Leonid Drozhinin
Student in an Organized Health Care Education/Training Program — Payments: $12,226
Dr. Adam Becker, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,824
Dr. Dylan Greeney, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $6,445
Elizabeth Luckett, P.a, P.A
Student in an Organized Health Care Education/Training Program — Payments: $4,988
Ian Stamps, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,784